German antitrust authorities have blocked Asklepios’s previously-cleared acquisition of more than 10 percent in rival hospital cooperation Rhoen-Klinikum after finding Asklepios failed to meet concessions originally agreed upon for the deal. Reports say Germany’s Federal Cartel Office agreed in March to allow the buyout that would see 10.1 percent of Rhoen in control of Asklepios as long as Asklepios sold a hospital and medical center in one region. Since, the cooperative has reportedly not met those conditions; Rhoen told media that the watchdog has now blocked the buyout.
Featured News
Winston & Strawn and Taylor Wessing to Form Global Firm in Proposed 2026 Merger
Dec 15, 2025 by
CPI
Retailers Urge Judge to Block Visa, Mastercard Fee Settlement
Dec 15, 2025 by
CPI
House Passes INVEST Act, Sending Capital Access Overhaul to Senate
Dec 15, 2025 by
CPI
EU Trade Commissioner Warns Against Weakening Tech Rules Under US Pressure
Dec 15, 2025 by
CPI
South Korea’s Antitrust Chief Backs Stronger Rules for Digital Platforms
Dec 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Acqui-hiring
Dec 11, 2025 by
CPI
Anticompetitive Effects of Acquihires: Labor and Product Markets
Dec 11, 2025 by
Heski Bar-Isaac, Justin Johnson & Volker Nocke
Acquihires In the Technology Sector: Antitrust Scrutiny Through the Lens of Economics
Dec 11, 2025 by
Juliette Caminade, Rebecca Kirk Fair, Zsolt Udvari & Jeanne Vellard Smith
M&A in the AI Era: Considerations for Acquihiring
Dec 11, 2025 by
Ingrid Vandenborre, Kenneth Schwartz, Christopher Barlow, Page Griffin, Michael Cardella, Stuart Levi, Taylor Votek, Benjamin Salzer, Lisa G. Liu & Liz Kraus
Lock Them Up, or Take No Prisoners? Merger Policy and Acquiring AI Talent: Human Rights and Other Inconvenient Facts
Dec 11, 2025 by
Simon R. Pritchard